Fibrous Dysplasia of Bone [PDF]
Acta Radiologica, 1949 In the autumn of 1947 the Department of Neurosurgery, State Hospital, Copenhagen, admitted a patient who caused certain diagnostic difficulties, clinical as well as radiological. Her case history will be reported below, and at the same time a few similar cases will be reviewed on the basis of studies of the literature.
H. H. Jacobsen, G. Vraa-Jensen
semanticscholar +8 more sources
Effects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience. [PDF]
Arch Endocrinol Metab, 2022 Objective: Fibrous dysplasia (FD) is a rare bone disorder that can involve any part of the skeleton, leading to bone pain, deformities, and fractures. Treatment with intravenous bisphosphonates has been used with variable results.
Valadares LP +6 more
europepmc +2 more sources
RANKL Inhibition in Fibrous Dysplasia of Bone: A Preclinical Study in a Mouse Model of the Human Disease. [PDF]
J Bone Miner Res, 2019 Fibrous dysplasia of bone/McCune‐Albright syndrome (Polyostotic FD/MAS; OMIM#174800) is a crippling skeletal disease caused by gain‐of‐function mutations of Gsα.
Palmisano B +12 more
europepmc +2 more sources
<sup>18</sup> F-NaF PET/CT IMAGING IN FIBROUS DYSPLASIA OF BONE. [PDF]
J Bone Miner Res, 2019 Fibrous dysplasia (FD) is a mosaic skeletal disorder resulting in fractures, deformity, and functional impairment. Clinical evaluation has been limited by a lack of surrogate endpoints capable of quantitating disease activity.
Papadakis GZ +7 more
europepmc +2 more sources
Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone. [PDF]
J Bone Miner Res, 2019 Fibrous dysplasia (FD) is a mosaic disease in which bone is replaced with fibro‐osseous tissue. Lesions expand during childhood, reaching final burden by age 15 years.
Florenzano P +8 more
europepmc +2 more sources
Mosaic Effects of Growth Hormone on Fibrous Dysplasia of Bone. [PDF]
N Engl J Med, 2018 Growth Hormone Effects in Mosaic Fibrous Dysplasia This case of mosaic fibrous dysplasia of bone shows hypersensitivity to growth hormone excess in affected bone, as compared with unaffected bone, ...
Roszko KL, Collins MT, Boyce AM.
europepmc +2 more sources
Fibrous Dysplasia Of Maxilla: A Case Report [PDF]
Journal of Rawalpindi Medical College, 2023 Summary: Fibrous dysplasia is a benign disease of unclear aetiology that is congenital and recurring in nature. It is caused by a problem known as bone modelling, in which the normal bone constantly changes and is replaced by immature fibrous tissue ...
Kinza Ayub +4 more
doaj +3 more sources
Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone. [PDF]
Br J Clin Pharmacol, 2019 Fibrous dysplasia (FD) is a genetic, noninheritable rare bone disease caused by a postzygotic activating mutation of the α subunit of the stimulatory G‐protein causing increased abnormal bone formation leading to pain, deformity and fractures.
Rotman M +2 more
europepmc +2 more sources
Fibrous dysplasia of bone: Surgical management options and outcomes of 22 cases. [PDF]
Mol Clin Oncol, 2018 The surgical treatment for fibrous dysplasia (FD) of bone is problematic due to its variable clinical courses. And multifarious surgical treatment options have been reported while no consistent view can be reached.
Fang X, Liu H, Lang Y, Xiong Y, Duan H.
europepmc +2 more sources
Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone. [PDF]
N Engl J Med, 2023 de Castro LF +13 more
europepmc +2 more sources